(S)-4-(3-氨基丁基)-苯酚 | 74248-90-1

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物 - 酚及其卤化、磺化、硝化或亚硝化衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: (S)-4-(3-氨基丁基)-苯酚
• 英文名称: S-1-methyl-3-(4-hydroxyphenyl)propylamine
• 英文别名: 4-(3-Aminobutyl)phenol, (S)-；4-[(3S)-3-aminobutyl]phenol
• CAS: 74248-90-1
• 化学式: C₁₀H₁₅NO
• 分子量: 165.235
• InChiKey: WNTVTQIJPAFZEL-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (S)-2-((4-(benzyloxy)phenoxy)methyl)oxirane 、 (S)-4-(3-氨基丁基)-苯酚 以 甲醇 为溶剂， 生成 4-{(S)-3-[(S)-3-(4-Benzyloxy-phenoxy)-2-hydroxy-propylamino]-butyl}-phenol
  参考文献：
  名称：

  Potent, selective benzenesulfonamide agonists of the human β3 adrenergic receptor

  摘要：

  A cloned human beta(3) adrenergic receptor assay was used to identify phenoxypropanolamine agonist 1. SAR studies led to the identification of benzenesulfonamide derivative 20, a 6.3 nM beta(3) agonist which shows 30-fold selectivity for beta(3) agonist activity over beta(1) and beta(2) receptor binding. Further refinement of this lead provided 4-bromo derivative 39, a subnanomolar agonist with 660-fold and 230-fold selectivity over beta(1) and beta(2), respectively. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00169-3

文献信息

• [EN] ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS<br/>[FR] TRANSAMINATION ENZYMATIQUE D'ANALOGUES DE CYCLOPAMINE
  申请人：INFINITY PHARMACEUTICALS INC

  公开号：WO2011017551A1

  公开（公告）日：2011-02-10

  Provided are processes for the synthesis of amino analogues from ketone starting materials

  提供从酮起始材料合成氨基类似物的过程。
• HETEROCYCLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THE USE THEREOF
  申请人：Zoller Gerhard

  公开号：US20110183998A1

  公开（公告）日：2011-07-28

  Heterocyclic derivatives, processes for their preparation, medicaments comprising these compounds, and the use thereof. The invention relates to compounds of the formula I in which the radicals R1, R2, R3, R4, W, A, B, D, E, G, L, M, R, T and Y have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example for the treatment of the metabolic syndrome, insulin resistance, obesity and diabetes.

  杂环衍生物、其制备方法、包含这些化合物的药物和其用途。本发明涉及式I中的化合物，其中基团R1、R2、R3、R4、W、A、B、D、E、G、L、M、R、T和Y具有所述的含义，并且其生理上可耐受的盐。该化合物适用于例如代谢综合征、胰岛素抵抗、肥胖和糖尿病的治疗。
• Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
  申请人：Zoller Gerhard

  公开号：US08470841B2

  公开（公告）日：2013-06-25

  Heterocyclic derivatives, processes for their preparation, medicaments comprising these compounds, and the use thereof. The invention relates to compounds of the formula I in which the radicals R1, R2, R3, R4, W, A, B, D, E, G, L, M, R, T and Y have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example for the treatment of the metabolic syndrome, insulin resistance, obesity and diabetes.

  杂环衍生物，其制备方法，包含这些化合物的药物和其用途。本发明涉及式I的化合物，其中基团R1，R2，R3，R4，W，A，B，D，E，G，L，M，R，T和Y具有所述的含义，并且其生理耐受盐。这些化合物适用于例如治疗代谢综合征，胰岛素抵抗，肥胖和糖尿病。
• Phenethanolamines, their formulations, use and preparation
  申请人：ELI LILLY AND COMPANY

  公开号：EP0007204A1

  公开（公告）日：1980-01-23

  Compounds of the formula (I): wherein: R1 is hydrogen or fluorine; R2 is methyl or ethyl; R, is hydroxy, C1-C4 alkanoyloxy, aminocarbonyl. methylaminocarbonyl or C1-C2 alkoxycarbonyl; C is an asymmetric carbon atom having the R absolute stereochemical configuration; and C is an asymmetric carbon atom having the S absolute stereochemical configuration; and pharmaceutically-acceptable salts thereof, are useful in the weight control of mammals.

  式 (I) 的化合物： 其中 R1 是氢或氟 R2 是甲基或乙基 R，是羟基、C1-C4 烷酰氧基、氨基羰基、甲氨基羰基或 C1-C2 烷氧基羰基； C 是具有 R 绝对立体化学构型的不对称碳原子；以及 C 是具有 S 绝对立体化学构型的不对称碳原子； 及其药学上可接受的盐类，可用于控制哺乳动物的体重。
• Optically active 1-alkyl-3-(4-substituted-phenyl)-propylamines
  申请人：ELI LILLY AND COMPANY

  公开号：EP0048037A1

  公开（公告）日：1982-03-24

  Compounds of the formula (IV) wherein: R2 is methyl or ethyl R3 is hydroxy, C1-C4 alkanoyloxy, aminocarbonyl, methylaminocarbonyl or C1-C2 alkoxycarboxyl; and C is an asymmetric carbon atom having the S absolute stereochemical configuration. The compounds are useful intermediates in the preparation of phenethanolamines having pharmaceutical properties.

  式（IV）化合物 其中 R2 是甲基或乙基 R3 是羟基、C1-C4 烷酰氧基、氨基羰基、甲氨基羰基或 C1-C2 烷氧基羧基；以及 C 是具有 S 绝对立体化学构型的不对称碳原子。 这些化合物是制备具有药物特性的苯乙醇胺的有用中间体。